On August 28, ASCENTAGE fell 5.2% in regular trading, trading at HK$34.96/share, with Turnover of HK$135 million.
Within the Biotechnology sector where ASCENTAGE belongs, the overall sector performance is weak. Among individual stocks, AKESO down 6.08%, INNOVENT BIO flat 0%, BEONE MEDICINES down 0.71%, EVEREST MED down 6.83%, CANSINOBIO down 10.23%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)